• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

High Rate of Head-and-Neck Cancer in Women Pinned to Smoking


ROCKVILLE. Md. -- Women appear to be particularly vulnerable to head-and-neck cancer from smoking, according to National Cancer Institute researchers.

ROCKVILLE. Md., Aug. 27 -- Women appear to be particularly vulnerable to head-and-neck cancer from smoking, according to National Cancer Institute researchers.

Men are about three times likelier to develop squamous cancers of the head and neck than women, but smoking may be to blame for the larger relative increase in these cancers in women, Christian C. Abnet, Ph.D., of the National Cancer Institute here, and colleagues, reported online in the Oct. 1 issue of Cancer.

Head-and-neck cancer includes squamous tumors at multiple sites including the oral cavity, oropharynx, hypopharynx, and larynx.

Five-year survival in the U.S. varies by cancer subsite, from 31% in the hypopharynx to 64% in the larynx, with cigarette smoking thought to be the strongest risk factor for the larynx, the researchers wrote.

The researchers' findings emerged from a study of 476,211 participants, ages 50 to 71, in the National Institutes of Health/American Association of Retired Persons (NIH-AARP) diet and health study.

At baseline, the median age of the cohort was 62.6. About 60% were men, well educated (20.4% had completed graduate school), and non-Hispanic white (92.6%).

Only 36.5% were never-smokers, and the rest were former or current smokers. Although more women than men were never smokers, and more men were former smokers, more women were current smokers than men, the researchers found.

Over the course of follow-up (1995 through 2000), 584 men and 175 women were diagnosed with head-and-neck cancer.

Among men, nonsmokers (24.4%), former smokers (36.9%), and current smoking (147.3) had higher rates of age-adjusted incidence of head and neck cancer per 100,000 person-years of follow-up than women did in each equivalent category of cigarette use.

For example, the researchers wrote, the age-adjusted incidence per 100,000 person years was 147.3 for men versus 75.7 for women.

However, the hazard ratios for head and neck cancer overall associated with smoking were significantly larger in women (12.96; 95% confidence interval [CI], 7.81-21.52) than in men (5.45, CI, 4.22-7.05; P for interaction

The researchers said that compared with women more men with head and neck cancers were never-smokers, suggesting that they are exposed to other risk factors, although alcohol use and pipe and cigar smoking were ruled out.

Occupational, hormonal (steroid hormones, for example), or viral factors (human papilloma virus) could have been involved, especially exposure to second-hand tobacco smoke.

Study limitations noted were lack of information on smoking duration, occupation, and smokeless tobacco use.

Finally, they said, this cohort was more educated, and less likely to include current smokers than the general U.S. population, perhaps limiting the generalizability to other subpopulations.

"Although we believe that the mechanism underlying these differences in the baseline risk observed in men and women merits further investigation, our results suggest that smoking is a strong risk factor for head and neck cancer in both sexes, and public health interventions should continue to focus on reducing smoking use by all," Dr. Abnet and his colleagues concluded.

Related Videos
Infectious disease specialist talks about COVID-19 vaccine development
COVID 19 impact on healthcare provider mental health
Physician mental health expert discusses impact of COVID-19 on health care workers
© 2024 MJH Life Sciences

All rights reserved.